We found that monocytes from convalescent COVID-19 patients expressed significantly lower levels of both TNF-α (Figure 7A) and IL-6 (Figure 7B) in response to LPS stimulation, consistent with our findings regarding the expression of activation markers (Figure 4) and cellular CD142 (Figure 6). The gene discussed is IL6; the disease is COVID-19.